Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Int J Clin Pract ; 68(8): 986-94, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24666884

ABSTRACT

AIMS: The purpose of this study was to assess the safety, tolerability and impact on overactive bladder (OAB) symptoms of a novel combination of tolterodine immediate-release (IR) 2 mg and delayed-release pilocarpine 9 mg in patients with OAB. METHODS: Eligible patients with OAB were randomised to each of three treatments [tolterodine/pilocarpine (2/9 mg), tolterodine IR 2 mg or placebo] twice daily for 4 weeks in a double-blind, crossover fashion. At the end of the 12-week, double-blind treatment period, patients could enter an open-label extension during which they were re-randomised to either tolterodine/pilocarpine (3/13.5 mg) twice daily or tolterodine extended-release 4 mg once daily for 12 weeks. RESULTS: A total of 138 patients were randomised to double-blind medication. Both tolterodine/pilocarpine (2/9) and tolterodine IR 2 mg significantly reduced incontinence episodes and daily micturitions (p < 0.001 vs. placebo), with similar reductions in symptoms observed between active treatment groups. Tolterodine/pilocarpine (2/9) was associated with consistently lower Visual Analogue Scale (VAS) scores for all dry mouth parameters compared with tolterodine alone. Salivary flow over a 3 h period remained fairly constant after tolterodine/pilocarpine (2/9) administration, similar to placebo, but decreased markedly after administration of tolterodine alone. In the extension study, patients receiving tolterodine/pilocarpine (3/13.5) reported comparable dry mouth VAS scores to tolterodine extended-release alone without additional side effects or loss of efficacy. The combination was well tolerated, and the adverse effects observed were consistent with the known safety profiles of tolterodine and pilocarpine. CONCLUSIONS: A combination of tolterodine/pilocarpine (2/9) effectively reduced the incidence of dry mouth compared with tolterodine IR alone while maintaining treatment efficacy in OAB.


Subject(s)
Drug Combinations , Drug Tolerance , Pilocarpine/therapeutic use , Tolterodine Tartrate/therapeutic use , Treatment Outcome , Urinary Bladder, Overactive/drug therapy , Adult , Aged , Cross-Over Studies , Double-Blind Method , Female , Humans , Middle Aged , Muscarinic Antagonists/adverse effects , Pilocarpine/administration & dosage , Pilocarpine/adverse effects , Tolterodine Tartrate/administration & dosage , Tolterodine Tartrate/adverse effects
2.
Mar Pollut Bull ; 52(11): 1364-71, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16790252

ABSTRACT

Six marine sediment cores from the Gulf of Lions continental slope (700-1700 m water depth) were analyzed for stable lead isotopes and (210)Pb geochronology in order to reconstruct lead atmospheric fallout pattern during the last century. The detrital lead contribution is 25 microg g(-1) and the mean sediment anthropogenic inventory is 110+/-7 microg cm(-2), a little bit higher than atmospheric deposition estimate. Anthropogenic lead accumulation in sediments peaked in early 1970s (1973+/-2) in agreement with lead emissions features. For the period 1986-1997, the sediment signal also reflect the decrease of atmospheric lead described by independent atmospheric fallout investigations. The anthropogenic Pb deposition in the late 1990s was similar to the 1950s deposition, attesting thus of the output of European environmental policies.


Subject(s)
Environmental Monitoring/statistics & numerical data , Environmental Pollutants/analysis , Geologic Sediments/analysis , Lead/analysis , Air Pollution/analysis , Mass Spectrometry , Mediterranean Sea , Models, Theoretical
3.
Electrophoresis ; 23(20): 3589-98, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12412129

ABSTRACT

The present report describes the design and application of a dual sprayer system for high-throughput proteome analysis. This system comprises parallel solid-phase extraction cartridges used for preconcentration and desalting of proteolytic digests prior to nanoelectrospray mass spectrometry analyses. Tryptic peptides from in-gel digest of protein bands/spots are first adsorbed on styrene divinyl benzene membrane and subsequently eluted with a short plug of organic buffer prior to infusion to the mass spectrometer at a flow rate of typically 500 nL/min. Tryptic peptide eluting from the membrane are analyzed by the mass spectrometer by moving in turn each sprayer in front of the sampling orifice. Sequential injection, preconcentration and analyses of tryptic digests are typically achieved with a throughput of up to 3.5 min/sample and a detection limit of approximately 8-80 fmol per injection. Replicate injections of peptide mixtures indicated that reproducibility of peak areas ranged from relative standard deviations (RSD) of 1.1% to 4.5%. The application of this device is demonstrated for digests of gel-isolated proteins obtained from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) separation of rat liver plasma membrane and from two-dimensional gel electrophoresis of total cell lysate extracts from human prostatic cancer cell.


Subject(s)
Electrophoresis, Gel, Two-Dimensional/methods , Proteins/analysis , Angiotensin I/isolation & purification , Animals , Electrophoresis, Gel, Two-Dimensional/instrumentation , Electrophoresis, Polyacrylamide Gel/methods , Enkephalin, Leucine/isolation & purification , Enkephalin, Methionine/isolation & purification , Humans , Male , Membranes, Artificial , Miniaturization , Prostate/chemistry , Proteins/isolation & purification , Rats
4.
Proteomics ; 1(8): 975-86, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11683514

ABSTRACT

An integrated microsystem providing rapid analyses of trace-level tryptic digests for proteomics application is presented. This modular microsystem includes an autosampler and a microfabricated device comprising a sample introduction port and an array of separation channels together with a low dead-volume facilitating the interface to nanoelectrospray mass spectrometry. Sequential injection and separation of peptide standards and tryptic digests was achieved with a throughput of up to 30 samples per hour with less than 3% sample carryover. Replicate injections of peptide mixtures indicated that reproducibility of migration time was typically better than 2.3% relative standard deviation (RSD) whereas RSD values of 3.7-11.8% were observed on peak height. Mass spectral detection of submicromolar protein digests (< 7 femtomoles/injection) was achieved using a quadrupole/time of flight instrument in less than 2 min/per sample with peak widths of 1.8-7.0 s. The analytical potential of this integrated device for the identification of gel isolated proteins from Neisseria meningitidis immunotype L3 has been demonstrated using both peptide mass-fingerprint database searching and on-line tandem mass spectrometry.


Subject(s)
Electrophoresis, Capillary/methods , Proteins/chemistry , Spectrometry, Mass, Electrospray Ionization/methods , Amino Acid Sequence , Nanotechnology , Reproducibility of Results , Systems Integration
5.
Psychiatr Serv ; 52(6): 834-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11376236

ABSTRACT

This study attempted to identify critical components of a supported employment program that were strongly correlated with competitive employment outcomes in a state mental health system. Researchers used a supported employment fidelity scale to rate programs at ten community mental health centers in Vermont. The staff at the centers concurrently assessed competitive employment outcomes for 2,639 clients who had been diagnosed as having severe and persistent mental illness. Higher competitive employment rates were strongly correlated with overall program fidelity and with two program components, namely, providing services in the community as opposed to providing them in the clinic and using full-time employment specialists as opposed to staff with mixed roles.


Subject(s)
Community Mental Health Services , Employment, Supported/organization & administration , Mental Disorders/rehabilitation , Adolescent , Adult , Humans , Middle Aged , Program Evaluation/methods , Reproducibility of Results , Vermont
6.
Can Oper Room Nurs J ; 16(4): 31-6, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10085821

ABSTRACT

The subject of this paper is a description of how perioperative nurses and other health care professionals worked together to meet the demands of change. New technologies and new techniques in cataract surgery with lens replacement has decreased dramatically the amount of operating room (OR) time required. With the reduction in OR time, the process of moving cataract patients through the perioperative experience became chaotic. Change was necessary. Planned change and teamwork made the change process less chaotic and more rewarding.


Subject(s)
Cataract Extraction/methods , Cataract Extraction/nursing , Operating Room Nursing/organization & administration , Humans , Organizational Innovation , Patient-Centered Care/organization & administration
7.
Biochem Cell Biol ; 64(4): 315-22, 1986 Apr.
Article in English | MEDLINE | ID: mdl-2872905

ABSTRACT

A single peak of tRNAGlu is obtained upon chromatography of unfractionated tRNA from Escherichia coli on DEAE-Sephadex A-50 if this tRNA was previously renatured, whereas two peaks of tRNAGlu are resolved if the sample chromatographed is a mixture of native (renatured) and denatured tRNA. Higher resolution analysis of native E. coli tRNA by RPC-5 chromatography showed that most of the tRNAGlu is present in one peak, eluted shortly after a minor peak containing about or less than 5% of the total amount of tRNAGlu; these two peaks were also observed with commercially available tRNAGlu purified from E. coli. When denatured, the tRNAGlu present in each of these two peaks was eluted from the RPC-5 column at a much lower salt concentration. The properties of the denatured conformers obtained from native tRNAGlu present in the major and minor peaks, and the variation, with growth conditions of E. coli, in the relative amount of tRNAGlu in the minor peak suggest that the tRNAGlu present in the minor peak is an undermodified form of the tRNAGlu present in the major peak. This tRNAGluUUC (or tRNAGluSUC when modified in the anticodon) would then be the only tRNA species acceptor of glutamate in E. coli.


Subject(s)
Escherichia coli/metabolism , RNA, Transfer, Amino Acyl/metabolism , Carbon Radioisotopes , Chromatography, High Pressure Liquid , Drug Stability , Escherichia coli/growth & development , Glutamates/metabolism , Glutamic Acid , Isomerism , Nucleic Acid Denaturation , RNA, Transfer/isolation & purification , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...